| 1 | (E)-3-[2,6-Dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]-thiazol-2-ylcarbamoyl]-phenyl]-2-methylacrylic acid | - | - | - | - | [1] 63 63 💬
|
| 2 | (E)-3-[2,6-Dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]-thiazol-2-ylcarbamoyl]-phenyl]-2methylacrylic acid | - | - | - | - | [1] 63 63 💬
|
| 3 | 10-mg dose of E5501 2G tablet | - | - | - | - | [1] 63 63 💬
|
| 4 | 10-mg dose of E5501 cyclodextrin oral solution | - | - | - | - | [1] 63 63 💬
|
| 5 | 10-mg dose of E5501 lipid-based oral | - | - | - | - | [1] 63 63 💬
|
| 6 | 10-mg dose of E5501-P21% powder | - | - | - | - | [1] 63 63 💬
|
| 7 | 5% (5g/100 ml) intravenous immunoglobin | - | - | - | - | [1] 63 63 💬
|
| 8 | [acetominofene] | - | - | - | - | [2] 11 11, 63 💬
|
| 9 | [ARGX-113] | - | - | - | - | [3] 11 11, 35, 63 💬
|
| 10 | [ETB115] | - | - | - | - | [2] 60 60, 63 💬
|
| 11 | [IMP-2] | - | - | - | - | [1] 63 63 💬
|
| 12 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 13 | [PRN1008] | - | - | - | - | [2] 35 35, 63 💬
|
| 14 | [Romiplostim] | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 15 | [TAK-079] | - | - | - | - | [1] 63 63 💬
|
| 16 | [UCB7665 ] | - | - | - | - | [1] 63 63 💬
|
| 17 | [UCB7665] | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [2] 11 11, 63 💬
|
| 18 | [VAY736] | - | - | - | - | [4] 49 49, 53, 61, 63 💬
|
| 19 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 20 | Acetaminophen and Diphenhydramine Only Product | [2] Acetaminophen Acetaminophen, Diphenhydramine | [5] Acetaminophen
Acetaminophen
,
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [3] HRH1 HRH1, PTGS1, PTGS2 💬
| [27] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 63 63 💬
|
| 21 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 22 | Acetominophen | - | - | - | - | [1] 63 63 💬
|
| 23 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 24 | Acide acétylsalicylique | - | - | - | - | [1] 63 63 💬
|
| 25 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 26 | Adenine | [1] Adenine Adenine | [1] Adenine
Adenine
💬
| - | - | [1] 63 63 💬
|
| 27 | AKR-501, YM-477 | - | - | - | - | [1] 63 63 💬
|
| 28 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [21] 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 29 | Alemtuzumab, Rituximab | [2] Alemtuzumab Alemtuzumab, Rituximab | [2] Alemtuzumab
Alemtuzumab
,
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 30 | All trans retinoic acid | - | - | - | - | [1] 63 63 💬
|
| 31 | All-trans retinoic acid | - | - | - | - | [2] 63 63, 94 💬
|
| 32 | All-trans retinoic acid (ATRA) | - | - | - | - | [1] 63 63 💬
|
| 33 | All-Trans Retinoid Acid(ATRA) | - | - | - | - | [1] 63 63 💬
|
| 34 | All-trans-retinoid acid | - | - | - | - | [1] 63 63 💬
|
| 35 | AMG 531 | - | - | - | - | [1] 63 63 💬
|
| 36 | AMG531 | - | - | - | - | [2] 60 60, 63 💬
|
| 37 | Amifostine | [1] Amifostine Amifostine | [2] Amifostine
Amifostine
,
Amifostine
💬
| - | - | [2] 28 28, 63 💬
|
| 38 | Aminophylline | [1] Aminophylline Aminophylline | [2] Aminophylline
Aminophylline
,
Aminophylline dihydrate
💬
| [18] ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬
| [23] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 63 63 💬
|
| 39 | Amoxicillin | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [9] 6 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
|
| 40 | Amoxicillin 50 mg/kg/day in 2 divided doses for 14 days. | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [1] 63 63 💬
|
| 41 | Amoxicillin hydrate | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [1] 63 63 💬
|
| 42 | Anti-CD19 CAR NK cells (KN5501) | - | - | - | - | [2] 49 49, 63 💬
|
| 43 | Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis. | - | - | - | - | [1] 63 63 💬
|
| 44 | Anti-CD20 monoclonal antibody and the BTK inhibitor | - | - | - | - | [2] 61 61, 63 💬
|
| 45 | Anti-CD38 antibody Injection | - | - | - | - | [3] 48 48, 61, 63 💬
|
| 46 | Anti-CD40L | - | - | - | - | [1] 63 63 💬
|
| 47 | Anti-CD40LdAb | - | - | - | - | [1] 63 63 💬
|
| 48 | Anti-D | - | - | - | - | [1] 63 63 💬
|
| 49 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 50 | Antox tablets(Mepaco) | - | - | - | - | [1] 63 63 💬
|
| 51 | Aprednisolon | - | - | - | - | [1] 63 63 💬
|
| 52 | ARGX-113 | - | - | - | - | [5] 11 11, 14, 35, 53, 63 💬
|
| 53 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 22 22, 34, 48, 49, 51, 63, 86, 158, 210, 231 💬
|
| 54 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 55 | Atorvastatin 10mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 63 63 💬
|
| 56 | Atorvastatin 20mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 63 63 💬
|
| 57 | Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet | [2] Acetylcysteine Acetylcysteine, Atorvastatin | [3] Acetylcysteine
Acetylcysteine
,
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 63 63 💬
|
| 58 | ATRA | - | - | - | - | [1] 63 63 💬
|
| 59 | Autologous anti-BCMA chimeric antigen receptor T cells | - | - | - | - | [1] 63 63 💬
|
| 60 | Autologous peripheral blood stem cell transplantation | - | - | - | - | [9] 28 28, 40, 41, 42, 45, 46, 49, 63, 283 💬
|
| 61 | Avatrombopag | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 62 | Avatrombopag (proposed) | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 63 | Avatrombopag 20 MG Oral Tablet | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 64 | AVATROMBOPAG MALEATE | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 65 | Avatrombopag Oral Tablet | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 66 | Avatrombopag tablets | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 67 | Avatrombopag+All trans retinoic acid | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 68 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 69 | B02BX05 | - | - | - | - | [1] 63 63 💬
|
| 70 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [24] 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 71 | Baricitinib 2 MG | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [3] 46 46, 53, 63 💬
|
| 72 | Baricitinib 2 MG [Olumiant] | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 63 63, 162 💬
|
| 73 | BCMA-CD19 cCAR T cells | - | - | - | - | [1] 63 63 💬
|
| 74 | Belantamab mafodotin | [1] Belantamab mafodotin Belantamab mafodotin | [1] Belantamab mafodotin
Belantamab mafodotin
💬
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [14] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [2] 28 28, 63 💬
|
| 75 | BELIMUMAB | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [17] 11 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
|
| 76 | Benlysta | - | - | - | - | [7] 43 43, 48, 49, 53, 63, 66, 222 💬
|
| 77 | BENLYSTA® (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 11 11, 63, 66, 222 💬
|
| 78 | BEXSERO – Sospensione iniettabile – Siringa preriempita | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 79 | BI 655064 | - | - | - | - | [2] 46 46, 63 💬
|
| 80 | Biological tests | - | - | - | - | [1] 63 63 💬
|
| 81 | Biological: M254 | - | - | - | - | [1] 63 63 💬
|
| 82 | BIVV009 6.5 grams | - | - | - | - | [1] 63 63 💬
|
| 83 | BIVV009 7.5 grams | - | - | - | - | [1] 63 63 💬
|
| 84 | BIVV020 | - | - | - | - | [3] 14 14, 61, 63 💬
|
| 85 | Blinded (Avatrombopoag tablets) | - | - | - | - | [1] 63 63 💬
|
| 86 | Blisibimod | [1] Blisibimod Blisibimod | [1] Blisibimod
Blisibimod
💬
| - | - | [5] 43 43, 44, 49, 63, 66 💬
|
| 87 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 88 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 89 | BMS-986004 | - | - | - | - | [1] 63 63 💬
|
| 90 | BMS-986004 1500 mg IV | - | - | - | - | [1] 63 63 💬
|
| 91 | BMS-986004 225 mg IV | - | - | - | - | [1] 63 63 💬
|
| 92 | BMS-986004 675 mg IV | - | - | - | - | [1] 63 63 💬
|
| 93 | BMS-986004 75 mg IV | - | - | - | - | [1] 63 63 💬
|
| 94 | BMS-986353 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 95 | BMS-986413 | - | - | - | - | [2] 63 63, 64 💬
|
| 96 | BMS-986414 | - | - | - | - | [2] 63 63, 64 💬
|
| 97 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [19] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
|
| 98 | BT595 | - | - | - | - | [2] 63 63, 65 💬
|
| 99 | Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan | - | - | - | - | [1] 63 63 💬
|
| 100 | Budoprutug | [1] Budoprutug Budoprutug | - | - | - | [3] 49 49, 63, 222 💬
|
| 101 | Bélimumab | - | - | - | - | [1] 63 63 💬
|
| 102 | Caffeic acid | - | - | - | - | [1] 63 63 💬
|
| 103 | Caffeic acid tablets | - | - | - | - | [1] 63 63 💬
|
| 104 | Caplacizumab | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [2] 63 63, 64 💬
|
| 105 | CAR-T cells | - | - | - | - | [1] 63 63 💬
|
| 106 | CART Infusion | - | - | - | - | [2] 61 61, 63 💬
|
| 107 | CC312 | - | - | - | - | [5] 46 46, 49, 51, 61, 63 💬
|
| 108 | CD19 UCAR-T cells | - | - | - | - | [5] 48 48, 49, 51, 53, 63 💬
|
| 109 | CD19/CD22/BCMA CAR-T cells(BZE2204) | - | - | - | - | [2] 49 49, 63 💬
|
| 110 | CD4-IgG | - | - | - | - | [1] 63 63 💬
|
| 111 | Cevidoplenib | [1] Cevidoplenib Cevidoplenib | - | - | - | [2] 46 46, 63 💬
|
| 112 | Chidamide | - | - | - | - | [1] 63 63 💬
|
| 113 | CID-103 | - | - | - | - | [1] 63 63 💬
|
| 114 | Clarithromycin | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [10] 6 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
|
| 115 | Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days. | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [1] 63 63 💬
|
| 116 | CM313 injection | - | - | - | - | [3] 35 35, 49, 63 💬
|
| 117 | CM336 Injection | - | - | - | - | [2] 61 61, 63 💬
|
| 118 | CNCT19 cell injection | - | - | - | - | [2] 49 49, 63 💬
|
| 119 | Collection of biological samples | - | - | - | - | [1] 63 63 💬
|
| 120 | Combination of Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 121 | Combination of Rituximab with subcutaneous belimumab | [2] Belimumab Belimumab, Rituximab | [2] Rituximab
Rituximab
,
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 63 63 💬
|
| 122 | Combination Product: Ripertamab/Eltrombopag | [2] Eltrombopag Eltrombopag, Ripertamab | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 123 | Combined use of TPO-RAs with low-dose anti-CD20 antibody | - | - | - | - | [1] 63 63 💬
|
| 124 | Conventional | - | - | - | - | [1] 63 63 💬
|
| 125 | Corticosteriod for treated patients | - | - | - | - | [1] 63 63 💬
|
| 126 | Corticosteroids | - | - | - | - | [13] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
|
| 127 | Corticosteroids (Aprednislon) | - | - | - | - | [1] 63 63 💬
|
| 128 | Corticosteroids combined with immunoglobulin and romiplostim | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 129 | CTX112 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 130 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 131 | Cyclosporin A | - | - | - | - | [12] 46 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
|
| 132 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 133 | Cytokine essays | - | - | - | - | [2] 61 61, 63 💬
|
| 134 | DACLIZUMAB | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [10] 13 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
|
| 135 | Danazol | [1] Danazol Danazol | [1] Danazol
Danazol
💬
| [3] AR AR, ESR1, PGR 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [5] 60 60, 63, 64, 65, 285 💬
|
| 136 | Dapsone | [1] Dapsone Dapsone | [1] Dapsone
Dapsone
💬
| - | - | [6] 35 35, 42, 60, 63, 84, 162 💬
|
| 137 | Dapsone (Disulone®) | [1] Dapsone Dapsone | [1] Dapsone
Dapsone
💬
| - | - | [1] 63 63 💬
|
| 138 | Daratumumab | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [13] 13 13, 16, 28, 39, 46, 48, 49, 60, 63, 222, 223, 288, 331 💬
|
| 139 | Daratumumab Injection | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [4] 16 16, 28, 49, 63 💬
|
| 140 | Daratumumab(Anti-CD38 Monoclonal Antibody) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 63 63 💬
|
| 141 | Darzalex | - | - | - | - | [3] 28 28, 49, 63 💬
|
| 142 | Decitabine | [1] Decitabine Decitabine | [1] Decitabine
Decitabine
💬
| [3] DNMT1 DNMT1, DNMT3A, DNMT3B 💬
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬 | [2] 60 60, 63 💬
|
| 143 | DESAMETASONE | - | - | - | - | [3] 28 28, 63, 90 💬
|
| 144 | Desametasone 40mg | - | - | - | - | [1] 63 63 💬
|
| 145 | DEX Combined With RTX, CSA and IVIG | - | - | - | - | [1] 63 63 💬
|
| 146 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 147 | Dexamethasone (1 cycle) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 148 | Dexamethasone (4 cycles) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 149 | Dexamethasone Abcur | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 150 | DEXAMETHASONE ACETATE | [3] Acetate Acetate, Dexamethasone, Dexamethasone acetate | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone acetate
,
Dexamethasone 21-acetate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 151 | Dexamethasone and Rituximab | [2] Dexamethasone Dexamethasone, Rituximab | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 152 | Dexamethasone Combined with romiplostim N01 | [2] Dexamethasone Dexamethasone, Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 153 | Dexamethasone monotherapy | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 154 | Dexamethasone oral | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 155 | Dexamethasone palmitate | [2] Dexamethasone Dexamethasone, Dexamethasone palmitate | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone palmitate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 156 | Dexamethasone USP Micronized | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 157 | DIACEREIN | [1] Diacerein Diacerein | [1] Diacerein
Diacerein
💬
| - | - | [3] 36 36, 46, 63 💬
|
| 158 | Diagnostic Test: complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-?. | - | - | - | - | [1] 63 63 💬
|
| 159 | Diagnostic Test: complete blood picture | - | - | - | - | [1] 63 63 💬
|
| 160 | Diagnostic Test: estimation of serum level of IL17 | - | - | - | - | [1] 63 63 💬
|
| 161 | Diagnostic Test: estimation of serum level of IL2 | - | - | - | - | [1] 63 63 💬
|
| 162 | Diagnostic Test: Laboratory test | - | - | - | - | [1] 63 63 💬
|
| 163 | Diagnostic Test: Lactate dehydrogenase | - | - | - | - | [1] 63 63 💬
|
| 164 | Diagnostic Test: Plasma RNA isolation, qPCR analysis of micro RNA | - | - | - | - | [1] 63 63 💬
|
| 165 | Diagnostic Test: Quantitative microbiological test for HCV | - | - | - | - | [1] 63 63 💬
|
| 166 | Diagnostic Test: Search for thyroid disorders | - | - | - | - | [1] 63 63 💬
|
| 167 | Diagnostic Test: Serological assay for blood born viral hepatitis | - | - | - | - | [1] 63 63 💬
|
| 168 | Diagnostic Test: Serum IL10 By ELISA | - | - | - | - | [1] 63 63 💬
|
| 169 | Diagnostic Test: serum interleukin 10 level | - | - | - | - | [1] 63 63 💬
|
| 170 | Diagnostic Test: SNP -3279 A/C of FOXP3 | - | - | - | - | [1] 63 63 💬
|
| 171 | Diagnostic Test: SNP-924 A/G Of FOXP3 | - | - | - | - | [1] 63 63 💬
|
| 172 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | [1] 63 63 💬
|
| 173 | Difenidramina | - | - | - | - | [2] 11 11, 63 💬
|
| 174 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | [3] 11 11, 19, 63 💬
|
| 175 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 176 | Discontinuation of eltrombopag | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 177 | Doptelet 20 mg film-coated tablets | - | - | - | - | [1] 63 63 💬
|
| 178 | Doxil | - | - | - | - | [1] 63 63 💬
|
| 179 | Dyphenhydramine hydrochloride | - | - | - | - | [1] 63 63 💬
|
| 180 | DZD8586 dose level 1 | - | - | - | - | [1] 63 63 💬
|
| 181 | DZD8586 dose level 2 | - | - | - | - | [1] 63 63 💬
|
| 182 | DZD8586 dose level 3 | - | - | - | - | [1] 63 63 💬
|
| 183 | E5501 | - | - | - | - | [1] 63 63 💬
|
| 184 | E5501 40 mg 2 x 20-mg tablets, orally, fasted | - | - | - | - | [1] 63 63 💬
|
| 185 | E5501 40 mg 2 x 20-mg tablets, orally, with food | - | - | - | - | [1] 63 63 💬
|
| 186 | E5501 40mg 2 x 20-mg tablets, orally, fasted | - | - | - | - | [1] 63 63 💬
|
| 187 | Efgartigimod | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [8] 11 11, 14, 35, 36, 53, 63, 64, 300 💬
|
| 188 | EFGARTIGIMOD ALFA | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [7] 11 11, 13, 14, 35, 53, 63, 162 💬
|
| 189 | Efgartigimod alpha | - | - | - | - | [1] 63 63 💬
|
| 190 | Efgartigimod IV | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [3] 11 11, 63, 222 💬
|
| 191 | Efgartigimod PH20 SC | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | [7] 11 11, 14, 35, 50, 53, 63, 162 💬
|
| 192 | ELTROMBOPAG | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [5] 60 60, 63, 65, 284, 285 💬
|
| 193 | Eltrombopag (Revolade) | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 194 | Eltrombopag (Revolade®) | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 195 | Eltrombopag 25 mg | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 196 | Eltrombopag and dexamethasone | [2] Dexamethasone Dexamethasone, Eltrombopag | [5] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Eltrombopag olamine
,
Dexamethasone phosphate
,
Eltrombopag choline
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 197 | Eltrombopag and romiplastim | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 198 | Eltrombopag combining rituximab | [2] Eltrombopag Eltrombopag, Rituximab | [3] Rituximab
Rituximab
,
Eltrombopag olamine
,
Eltrombopag choline
💬
| [2] MPL MPL, MS4A1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 199 | ELTROMBOPAG OLAMINE | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 200 | Eltrombopag olamine (SB-497115-GR) | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 201 | Eltrombopag olamine, Revolade, Promacta | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 202 | Eltrombopag oral tablets | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 203 | Eltrombopag PfOS | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 204 | Eltrombopag plus diacerein | [2] Diacerein Diacerein, Eltrombopag | [3] Eltrombopag olamine
Eltrombopag olamine
,
Diacerein
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 205 | ERYTHROPOIETIN | [1] Erythropoietin Erythropoietin | [4] Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| [1] EPOR EPOR 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [11] 2 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
|
| 206 | ESG206 | - | - | - | - | [2] 53 53, 63 💬
|
| 207 | ETB115 | - | - | - | - | [2] 60 60, 63 💬
|
| 208 | Ethanolamine | [1] Ethanolamine Ethanolamine | [1] Monoethanolamine
Monoethanolamine
💬
| - | - | [3] 60 60, 63, 279 💬
|
| 209 | Fecal microbiome | - | - | - | - | [2] 61 61, 63 💬
|
| 210 | Fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [14] 2 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
|
| 211 | Fecal microbiota transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [9] 2 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
|
| 212 | Filgrastim | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [30] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 213 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 214 | Fludarabine phosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [14] 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 215 | Fostamatinib | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 49, 61, 63, 66 💬
|
| 216 | Fostamatinib Disodium | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 61, 63, 66 💬
|
| 217 | Fostamatinib Disodium / R935788 | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 63 63 💬
|
| 218 | Fostamatinib disodium 100 mg | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 63 63 💬
|
| 219 | Fostamatinib disodium 150 mg | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 63 63 💬
|
| 220 | Fostamatinib disodium tablets | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 63 63 💬
|
| 221 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [12] 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 222 | Gammaplex | - | - | - | - | [2] 63 63, 65 💬
|
| 223 | Gammaplex, intravenous immunoglobulin | - | - | - | - | [1] 63 63 💬
|
| 224 | Genetic: CD19 and BCMA-targeted allogeneic CAR-T cells | - | - | - | - | [1] 63 63 💬
|
| 225 | Genetic: Global DNA methylation will be quantified in the DNA samples by colorimetry | - | - | - | - | [1] 63 63 💬
|
| 226 | GL-2045 | [1] GL-2045 GL-2045 | - | - | - | [1] 63 63 💬
|
| 227 | Glycyrrhetinic Acid | - | - | - | - | [1] 63 63 💬
|
| 228 | GMA161 | - | - | - | - | [1] 63 63 💬
|
| 229 | GNR-069 | - | - | - | - | [1] 63 63 💬
|
| 230 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 231 | GP404141 | - | - | - | - | [1] 63 63 💬
|
| 232 | GSK1550188 | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 233 | H. pylori triple therapy | - | - | - | - | [1] 63 63 💬
|
| 234 | HAEMOPHILUS INFLUENZAE | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 235 | HBM9161 Dose A | - | - | - | - | [1] 63 63 💬
|
| 236 | HBM9161 Dose B | - | - | - | - | [1] 63 63 💬
|
| 237 | HD-DXM | - | - | - | - | [1] 63 63 💬
|
| 238 | Herombopag | - | - | - | - | [2] 60 60, 63 💬
|
| 239 | Herombopag olamine tablets | - | - | - | - | [1] 63 63 💬
|
| 240 | Hetrombopag | [1] Hetrombopag Hetrombopag | - | - | - | [2] 60 60, 63 💬
|
| 241 | Hetrombopag 5mg po qd | [1] Hetrombopag Hetrombopag | - | - | - | [1] 63 63 💬
|
| 242 | Hetrombopag Olamine | [1] Hetrombopag Hetrombopag | - | - | - | [2] 60 60, 63 💬
|
| 243 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 244 | High dose dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 245 | High dose Dexamethasone pulses | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 246 | High-dose Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 247 | High-Dose Dexamethasone Combined | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 248 | High-Dose Dexamethasone Combined with Orelabrutinib | [2] Dexamethasone Dexamethasone, Orelabrutinib | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Orelabrutinib
💬
| [2] BTK BTK, NR3C1 💬
| [8] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 249 | Higher Dose of Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 250 | HMPL-523 | - | - | - | - | [2] 46 46, 63 💬
|
| 251 | Honey | [1] Honey Honey | [1] Honey
Honey
💬
| - | - | [4] 57 57, 63, 98, 230 💬
|
| 252 | Huaiqihuang Granule | - | - | - | - | [2] 63 63, 222 💬
|
| 253 | Human Immunoglobulin | - | - | - | - | [2] 63 63, 65 💬
|
| 254 | Human immunoglobulin (pH4) for intravenous injection | - | - | - | - | [1] 63 63 💬
|
| 255 | HUMAN IMMUNOGLOBULIN G | [1] Human immunoglobulin G Human immunoglobulin G | [1] Globulin, immune
Globulin, immune
💬
| - | - | [4] 14 14, 50, 63, 65 💬
|
| 256 | Human immunoglobulin intravenous | - | - | - | - | [1] 63 63 💬
|
| 257 | Human normal immunoglobulin | - | - | - | - | [6] 13 13, 14, 50, 51, 63, 65 💬
|
| 258 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | - | - | - | - | [4] 11 11, 14, 63, 65 💬
|
| 259 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | - | - | - | - | [2] 63 63, 65 💬
|
| 260 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE | - | - | - | - | [1] 63 63 💬
|
| 261 | Human normal immunoglobulin G (IgG > 98% purity) | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 262 | HUMAX-CD38 | - | - | - | - | [2] 28 28, 63 💬
|
| 263 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 264 | Hydroxychloroquine Oral Tablet | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [2] 63 63, 66 💬
|
| 265 | Hypersialylated immunoglobulin | - | - | - | - | [1] 63 63 💬
|
| 266 | I10E | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 267 | Ianalumab | [1] Ianalumab Ianalumab | [1] Ianalumab
Ianalumab
💬
| [1] TNFRSF13C TNFRSF13C 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | [8] 35 35, 46, 49, 51, 53, 61, 63, 95 💬
|
| 268 | IanalumabProduct Code: VAY736Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: IanalumabCurrent Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [2] 61 61, 63 💬
|
| 269 | Ig VENA | - | - | - | - | [2] 50 50, 63 💬
|
| 270 | Ig VENA 100 ml vial | - | - | - | - | [1] 63 63 💬
|
| 271 | Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set | - | - | - | - | [2] 63 63, 65 💬
|
| 272 | IgG Next Generation | - | - | - | - | [2] 63 63, 65 💬
|
| 273 | IGIV3I Grifols | - | - | - | - | [1] 63 63 💬
|
| 274 | IGIV3I Grifols 10% | - | - | - | - | [1] 63 63 💬
|
| 275 | IgNextGen 10% | - | - | - | - | [1] 63 63 💬
|
| 276 | IgPro10 | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 277 | Iguratimod | [1] Iguratimod Iguratimod | [1] Iguratimod
Iguratimod
💬
| [1] NFKB1 NFKB1 💬
| [76] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [7] 46 46, 49, 51, 53, 63, 271, 300 💬
|
| 278 | Immune Globulin Intravenous (human), 10% | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 279 | Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution | - | - | - | - | [1] 63 63 💬
|
| 280 | Immunglobulin | - | - | - | - | [1] 63 63 💬
|
| 281 | Immunoglobulin | - | - | - | - | [3] 13 13, 14, 63 💬
|
| 282 | IMMUNOGLOBULIN G | - | - | - | - | [9] 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 283 | Immunoglobulin Intravenous (Human) | - | - | - | - | [2] 63 63, 65 💬
|
| 284 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 285 | Inactivated Trivalent Influenza vaccine | - | - | - | - | [1] 63 63 💬
|
| 286 | Inaticabtagene Autoleucel | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 287 | Inaticabtagene autoleucel Injection | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 288 | INCA000585 | - | - | - | - | [1] 63 63 💬
|
| 289 | Interleukin 10 | - | - | - | - | [2] 46 46, 63 💬
|
| 290 | Interleukin 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
|
| 291 | Intravenous Immunoglobulin | - | - | - | - | [9] 13 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
|
| 292 | Intravenous immunoglobulin (IVIg) | - | - | - | - | [8] 14 14, 17, 19, 63, 65, 85, 164, 296 💬
|
| 293 | Intravenous immunoglobulin (IVIG), 10% solution for infusion | - | - | - | - | [2] 2 2, 63 💬
|
| 294 | Intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO) | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1] 63 63 💬
|
| 295 | Intravenous immunoglobulins | - | - | - | - | [1] 63 63 💬
|
| 296 | Iptacopan | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [8] 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 297 | Iptacopan hydrochloride | [1] Iptacopan Iptacopan | [2] Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| [1] CFB CFB 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | [5] 61 61, 63, 66, 109, 223 💬
|
| 298 | IVIG | - | - | - | - | [8] 11 11, 13, 14, 18, 51, 63, 65, 172 💬
|
| 299 | IVIG infusion | - | - | - | - | [1] 63 63 💬
|
| 300 | IVIG-L | - | - | - | - | [1] 63 63 💬
|
| 301 | JCXH-213 | - | - | - | - | [1] 63 63 💬
|
| 302 | Kardégic | - | - | - | - | [1] 63 63 💬
|
| 303 | Kedrion IVIG 10% | - | - | - | - | [2] 63 63, 65 💬
|
| 304 | KZR-616 | - | - | - | - | [4] 49 49, 50, 61, 63 💬
|
| 305 | L01FC01 | - | - | - | - | [1] 63 63 💬
|
| 306 | Lansoprazole | [1] Lansoprazole Lansoprazole | [1] Lansoprazole
Lansoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [8] 63 63, 71, 85, 98, 166, 222, 223, 299 💬
|
| 307 | Lansoprazole, clarithromycin, amoxycillin | [2] Clarithromycin Clarithromycin, Lansoprazole | [2] Clarithromycin
Clarithromycin
,
Lansoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 63 63 💬
|
| 308 | Levofloxacin | [1] Levofloxacin Levofloxacin | [2] Levofloxacin
Levofloxacin
,
Levofloxacin
💬
| - | - | [5] 46 46, 53, 63, 84, 299 💬
|
| 309 | Levofloxacin-Based H. pylori Eradication Therapy | [1] Levofloxacin Levofloxacin | [2] Levofloxacin
Levofloxacin
,
Levofloxacin
💬
| - | - | [1] 63 63 💬
|
| 310 | LGD-4665 | - | - | - | - | [1] 63 63 💬
|
| 311 | LIV-GAMMA SN Inj. | - | - | - | - | [1] 63 63 💬
|
| 312 | LIV-GAMMA SN Inj.10% | - | - | - | - | [1] 63 63 💬
|
| 313 | LNP023 | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|
| 314 | Low-dose rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 315 | Luspatercept | [1] Luspatercept Luspatercept | [1] Luspatercept
Luspatercept
💬
| [1] ACVR2B ACVR2B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [4] 60 60, 61, 63, 282 💬
|
| 316 | Lusutrombopag | [1] Lusutrombopag Lusutrombopag | [1] Lusutrombopag
Lusutrombopag
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 317 | Lusutrombopag Oral Tablet | [1] Lusutrombopag Lusutrombopag | [1] Lusutrombopag
Lusutrombopag
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 318 | Lymphostat B | - | - | - | - | [1] 63 63 💬
|
| 319 | M254 | - | - | - | - | [1] 63 63 💬
|
| 320 | Mabthera | - | - | - | - | [20] 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 321 | Mabthera® | - | - | - | - | [7] 13 13, 35, 43, 44, 46, 63, 93 💬
|
| 322 | Mabthéra | - | - | - | - | [3] 35 35, 63, 162 💬
|
| 323 | Medical Standard of Care for ITP | - | - | - | - | [1] 63 63 💬
|
| 324 | MENVEO – Polvere e soluzione per soluzione iniettabile | - | - | - | - | [4] 61 61, 62, 63, 223 💬
|
| 325 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 326 | Methylprednisolone and IVIG | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 327 | METILPREDNISOLONE | - | - | - | - | [5] 11 11, 53, 56, 63, 300 💬
|
| 328 | METRONIDAZOLE | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [7] 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 329 | Mezagitamab | [1] Mezagitamab Mezagitamab | [1] Mezagitamab
Mezagitamab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3] 63 63, 66, 223 💬
|
| 330 | Mini-Pool IVIG | - | - | - | - | [1] 63 63 💬
|
| 331 | MK-8723 | - | - | - | - | [1] 63 63 💬
|
| 332 | Montelukast | [1] Montelukast Montelukast | [2] Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| [1] CYSLTR1 CYSLTR1 💬
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [10] 6 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
|
| 333 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 334 | Mycophenolate Mofetil (MMF) Treatment | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 63 63 💬
|
| 335 | N.a. | - | - | - | - | [11] 3 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
|
| 336 | Nanogam | - | - | - | - | [2] 57 57, 63 💬
|
| 337 | Neofordex | - | - | - | - | [1] 63 63 💬
|
| 338 | Neofordex 40 mg comprimés | - | - | - | - | [1] 63 63 💬
|
| 339 | Neofordex® | - | - | - | - | [1] 63 63 💬
|
| 340 | NewGam | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 341 | NGS | - | - | - | - | [2] 61 61, 63 💬
|
| 342 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 343 | Nicotinamide adenine dinucleotid/nicotinamide mononucleotide | [3] Adenine Adenine, Nicotinamide, Nicotinamide Mononucleotide | [2] Adenine
Adenine
,
Niacinamide
💬
| - | - | [1] 63 63 💬
|
| 344 | Nicotinamide Mononucleotide | [2] Nicotinamide Nicotinamide, Nicotinamide Mononucleotide | [1] Niacinamide
Niacinamide
💬
| - | - | [2] 63 63, 97 💬
|
| 345 | Nimenrix | - | - | - | - | [4] 50 50, 61, 63, 223 💬
|
| 346 | Ninlaro | - | - | - | - | [2] 61 61, 63 💬
|
| 347 | Nplate | - | - | - | - | [2] 60 60, 63 💬
|
| 348 | NPLATE 500 microgramos polvo para solución inyectable | - | - | - | - | [1] 63 63 💬
|
| 349 | NVG-2089 | - | - | - | - | [2] 14 14, 63 💬
|
| 350 | Obinutuzumab | [1] Obinutuzumab Obinutuzumab | [1] Obinutuzumab
Obinutuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [6] 43 43, 44, 49, 63, 222, 223 💬
|
| 351 | Obinutuzumab Injection [Gazyva] | [1] Obinutuzumab Obinutuzumab | [1] Obinutuzumab
Obinutuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 352 | Octagam 10% | - | - | - | - | [3] 50 50, 63, 65 💬
|
| 353 | Octagam® 10% | - | - | - | - | [1] 63 63 💬
|
| 354 | OM336 | - | - | - | - | [2] 61 61, 63 💬
|
| 355 | Open Label (Avatrombopag tablets) | [1] Avatrombopag Avatrombopag | [2] Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 356 | Orelabrutinib | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [5] 13 13, 49, 53, 61, 63 💬
|
| 357 | Orelabrutinib( higher dose) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 358 | Orelabrutinib( lower dose) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 359 | Oseltamivir | [1] Oseltamivir Oseltamivir | [2] Oseltamivir phosphate
Oseltamivir phosphate
,
Oseltamivir
💬
| - | - | [3] 63 63, 97, 299 💬
|
| 360 | Other: Blood draw for future biomarker analysis | - | - | - | - | [2] 13 13, 63 💬
|
| 361 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 362 | Other: Blood Samples | - | - | - | - | [13] 3 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
|
| 363 | Other: drug therapy for ITP | - | - | - | - | [1] 63 63 💬
|
| 364 | Other: healthy controls | - | - | - | - | [1] 63 63 💬
|
| 365 | Other: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) | - | - | - | - | [1] 63 63 💬
|
| 366 | Other: peripheral blood and bone marrow withdrawal | - | - | - | - | [1] 63 63 💬
|
| 367 | Other: Spleen samples | - | - | - | - | [1] 63 63 💬
|
| 368 | PANZYGA | - | - | - | - | [2] 14 14, 63 💬
|
| 369 | PARACETAMOLO | - | - | - | - | [10] 2 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
|
| 370 | PF-06755347 intravenous healthy participant | - | - | - | - | [1] 63 63 💬
|
| 371 | PF-06755347 subcutaneous healthy participant | - | - | - | - | [1] 63 63 💬
|
| 372 | PF-06755347 subcutaneous ITP | - | - | - | - | [1] 63 63 💬
|
| 373 | PF-06835375 | - | - | - | - | [3] 46 46, 49, 63 💬
|
| 374 | PG2 | - | - | - | - | [1] 63 63 💬
|
| 375 | Pirtobrutinib | [1] Pirtobrutinib Pirtobrutinib | [1] Pirtobrutinib
Pirtobrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2] 13 13, 63 💬
|
| 376 | Platelet Concentrate | - | - | - | - | [1] 63 63 💬
|
| 377 | PN20 | - | - | - | - | [1] 63 63 💬
|
| 378 | PN20 treatment | - | - | - | - | [1] 63 63 💬
|
| 379 | Povetacicept | [1] Povetacicept Povetacicept | [1] Povetacicept
Povetacicept
💬
| [1] TNFRSF13B TNFRSF13B 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬 | [5] 11 11, 61, 63, 66, 222 💬
|
| 380 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 381 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 382 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 383 | Prednisone (Cortancyl®) | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 384 | Prednisone (Cortancyl®) alone followed by monitoring and standard of care | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 385 | Prednisone acetate | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] Prednisone
Prednisone
,
Prednisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 35 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
|
| 386 | Prednisone tablet | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 387 | PRG-1801 | - | - | - | - | [2] 63 63, 300 💬
|
| 388 | PRIVIGEN | - | - | - | - | [6] 11 11, 14, 51, 63, 65, 222 💬
|
| 389 | Privigen® | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 390 | PRN1008 | - | - | - | - | [4] 35 35, 61, 63, 300 💬
|
| 391 | PRN1008 100 mg tablet | - | - | - | - | [1] 63 63 💬
|
| 392 | PRN1008 300 mg tablet | - | - | - | - | [1] 63 63 💬
|
| 393 | PRN1008 400 mg tablet | - | - | - | - | [1] 63 63 💬
|
| 394 | Probiotic Agent | - | - | - | - | [1] 63 63 💬
|
| 395 | Proteína recombinante estimulante de la megacariopoyesis | - | - | - | - | [1] 63 63 💬
|
| 396 | Proton pump inhibitor 1 mg/kg/day in 2 divided doses 1 month | - | - | - | - | [1] 63 63 💬
|
| 397 | PRTX-100 | [1] PRTX-100 PRTX-100 | - | - | - | [2] 46 46, 63 💬
|
| 398 | PRTX-100 (Staphylococcal protein A) | [1] PRTX-100 PRTX-100 | - | - | - | [1] 63 63 💬
|
| 399 | QL0911 | - | - | - | - | [1] 63 63 💬
|
| 400 | QT-019C | - | - | - | - | [5] 11 11, 13, 49, 51, 63 💬
|
| 401 | Quality-of-life assessment | - | - | - | - | [4] 28 28, 34, 51, 63 💬
|
| 402 | R788 | - | - | - | - | [2] 46 46, 63 💬
|
| 403 | R935788 | - | - | - | - | [4] 46 46, 61, 63, 66 💬
|
| 404 | Rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [13] 2 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
|
| 405 | RAY121 | - | - | - | - | [4] 48 48, 50, 63, 162 💬
|
| 406 | Recombinant Human Thrombopoietin | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [2] 60 60, 63 💬
|
| 407 | Recombinant human thrombopoietin (rh-TPO) | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1] 63 63 💬
|
| 408 | Recombinant Human Thrombopoietin (rhTPO) | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1] 63 63 💬
|
| 409 | Recombinant Human Thrombopoietin(rhTPO) | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1] 63 63 💬
|
| 410 | Recombinant Human TPO | - | - | - | - | [1] 63 63 💬
|
| 411 | Relovade | - | - | - | - | [1] 63 63 💬
|
| 412 | REVOLADE | - | - | - | - | [2] 60 60, 63 💬
|
| 413 | Revolade 25 mg film-coated tablets | - | - | - | - | [1] 63 63 💬
|
| 414 | Revolade 50 mg film-coated tablets | - | - | - | - | [1] 63 63 💬
|
| 415 | REVOLADE*28CPR RIV 25MG | - | - | - | - | [1] 63 63 💬
|
| 416 | REVOLADE, PROMACTA | - | - | - | - | [1] 63 63 💬
|
| 417 | RhIL-11 | - | - | - | - | [2] 63 63, 97 💬
|
| 418 | Rho(D) Immune Globulin | - | - | - | - | [1] 63 63 💬
|
| 419 | RhTPO | - | - | - | - | [2] 60 60, 63 💬
|
| 420 | RhTPO in combination with Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 421 | Rilzabrutinib | [1] Rilzabrutinib Rilzabrutinib | [1] Rilzabrutinib
Rilzabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [6] 35 35, 61, 63, 222, 223, 300 💬
|
| 422 | Ripertamab | [1] Ripertamab Ripertamab | - | - | - | [4] 11 11, 14, 63, 222 💬
|
| 423 | Rituxan | - | - | - | - | [5] 46 46, 60, 63, 256, 288 💬
|
| 424 | Rituxan, Cyclophosphamide, Vincristine, Prednisone | [3] Cyclophosphamide Cyclophosphamide, Prednisone, Vincristine | [5] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Vincristine sulfate
,
Cyclophosphamide
,
Vincristine
💬
| [10] NR3C1 NR3C1, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [13] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [1] 63 63 💬
|
| 425 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 426 | Rituximab (Arm B) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 43 43, 44, 63 💬
|
| 427 | Rituximab (Mabthera ®) Belimumab (Benlysta ®) | [2] Belimumab Belimumab, Rituximab | [2] Rituximab
Rituximab
,
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 63 63 💬
|
| 428 | Rituximab (Mabthera) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 14 14, 63 💬
|
| 429 | Rituximab (MABTHERA® or RITUXAN®). | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 35 35, 61, 63 💬
|
| 430 | Rituximab [MabThera/Rituxan] | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 46 46, 63 💬
|
| 431 | Rituximab and dexamethasone | [2] Dexamethasone Dexamethasone, Rituximab | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 432 | Rituximab combined with Daratumumab(Anti-CD38 Monoclonal Antibody) | [2] Daratumumab Daratumumab, Rituximab | [2] Rituximab
Rituximab
,
Daratumumab
💬
| [2] CD38 CD38, MS4A1 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 63 63 💬
|
| 433 | Rituximab plus methylprednisolone | [2] Methylprednisolone Methylprednisolone, Rituximab | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Rituximab
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 434 | Rocaltrol | - | - | - | - | [1] 63 63 💬
|
| 435 | Romiplostim | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [4] 60 60, 63, 64, 65 💬
|
| 436 | Romiplostim and danazol | [2] Danazol Danazol, Romiplostim | [2] Danazol
Danazol
,
Romiplostim
💬
| [4] AR AR, ESR1, MPL, PGR 💬
| [14] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, JAK-STAT signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 63 63 💬
|
| 437 | Romiplostim N01 | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [2] 60 60, 63 💬
|
| 438 | Romiplostim N01 combined with dexamethasone | [2] Dexamethasone Dexamethasone, Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 439 | Romiplostim plus dexamethasone | [2] Dexamethasone Dexamethasone, Romiplostim | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Romiplostim
💬
| [2] MPL MPL, NR3C1 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 63 63 💬
|
| 440 | Romiplostin | - | - | - | - | [1] 63 63 💬
|
| 441 | Ropivacaine | [1] Ropivacaine Ropivacaine | [2] Ropivacaine hydrochloride
Ropivacaine hydrochloride
,
Ropivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [7] 22 22, 36, 46, 63, 70, 71, 97 💬
|
| 442 | ROZANOLIXIZUMAB | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [3] 11 11, 14, 63 💬
|
| 443 | RozanolixizumabProduct Code: UCB7665Pharmaceutical Form: Solution for infusionINN or Proposed INN: ROZANOLIXIZUMABCAS Number: 1584645-37-3Current Sponsor code: UCB7665Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 140-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 63 63 💬
|
| 444 | S-888711 | - | - | - | - | [1] 63 63 💬
|
| 445 | SAR444671 | - | - | - | - | [3] 61 61, 63, 300 💬
|
| 446 | SAR445088 (BIVV020) | - | - | - | - | [1] 63 63 💬
|
| 447 | SB-497115 | - | - | - | - | [1] 63 63 💬
|
| 448 | SB-497115-GR | - | - | - | - | [1] 63 63 💬
|
| 449 | SB-497115-GR 12.5mg | - | - | - | - | [1] 63 63 💬
|
| 450 | SB-497115-GR 25mg | - | - | - | - | [1] 63 63 💬
|
| 451 | SB-497115-GR 50 mg | - | - | - | - | [1] 63 63 💬
|
| 452 | SB497115 | - | - | - | - | [2] 60 60, 63 💬
|
| 453 | Second Line ITP agents | - | - | - | - | [1] 63 63 💬
|
| 454 | SHR-2173 injection | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 455 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 456 | Sitagliptin | [1] Sitagliptin Sitagliptin | [3] Sitagliptin phosphate
Sitagliptin phosphate
,
Sitagliptin
,
Sitagliptin phosphate
💬
| [1] DPP4 DPP4 💬
| [2] Protein digestion and absorption Protein digestion and absorption, Virion - Hepatitis viruses 💬 | [6] 6 6, 63, 75, 77, 233, 299 💬
|
| 457 | SKI-O-703 | - | - | - | - | [2] 46 46, 63 💬
|
| 458 | SM101 | - | - | - | - | [3] 49 49, 63, 66 💬
|
| 459 | SM101 20mg/mL | - | - | - | - | [1] 63 63 💬
|
| 460 | SM101 5mg/mL | - | - | - | - | [1] 63 63 💬
|
| 461 | Spleen sample | - | - | - | - | [2] 61 61, 63 💬
|
| 462 | Standard of Care | - | - | - | - | [18] 6 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
|
| 463 | Standard therapy (without eltrombopag): HD-DXM | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 464 | Steroid and eltrombopage | - | - | - | - | [1] 63 63 💬
|
| 465 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬
|
| 466 | STSA-1301 subcutaneous injection | - | - | - | - | [1] 63 63 💬
|
| 467 | Sym001 | - | - | - | - | [1] 63 63 💬
|
| 468 | T cell injection targeting CD19 chimeric antigen receptor | - | - | - | - | [7] 46 46, 49, 51, 53, 63, 93, 300 💬
|
| 469 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 470 | TAK-079 | - | - | - | - | [3] 11 11, 49, 63 💬
|
| 471 | Telitacicept | [1] Telitacicept Telitacicept | - | - | - | [14] 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|
| 472 | Terbutaline | [1] Terbutaline Terbutaline | [2] Terbutaline sulfate
Terbutaline sulfate
,
Terbutaline
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 63 63, 118 💬
|
| 473 | TERIFLUNOMIDE | [1] Teriflunomide Teriflunomide | [1] Teriflunomide
Teriflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [4] 13 13, 25, 26, 63 💬
|
| 474 | Thalidomide | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 2 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
| 475 | The best available therapy | - | - | - | - | [1] 63 63 💬
|
| 476 | Thrombopoietin | [1] Thrombopoietin Thrombopoietin | - | - | - | [4] 47 47, 60, 61, 63 💬
|
| 477 | Thrombopoietin Receptor Agonist | [1] Thrombopoietin Thrombopoietin | - | - | - | [3] 60 60, 61, 63 💬
|
| 478 | Thrombopoietin receptor agonist (TPO-RA) | [1] Thrombopoietin Thrombopoietin | - | - | - | [3] 60 60, 61, 63 💬
|
| 479 | TPO | - | - | - | - | [1] 63 63 💬
|
| 480 | TPO-RA | - | - | - | - | [1] 63 63 💬
|
| 481 | Tpo-RA discontinuation | - | - | - | - | [1] 63 63 💬
|
| 482 | TPO-RAs | - | - | - | - | [1] 63 63 💬
|
| 483 | TPO-RAs combining anti-CD 20 monoclonal antibody | - | - | - | - | [1] 63 63 💬
|
| 484 | TQB3473 Tablets | - | - | - | - | [1] 63 63 💬
|
| 485 | Treatment : H. pylori eradication | - | - | - | - | [1] 63 63 💬
|
| 486 | Tretinoin | [1] Tretinoin Tretinoin | [1] Tretinoin
Tretinoin
💬
| [3] PML PML, RARA, RARB 💬
| [12] Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | [4] 2 2, 62, 63, 75 💬
|
| 487 | Triple therapy | - | - | - | - | [2] 50 50, 63 💬
|
| 488 | TYSABRI | - | - | - | - | [3] 13 13, 25, 63 💬
|
| 489 | UCB7665 | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬
| - | - | [3] 11 11, 14, 63 💬
|
| 490 | Universal STAR-T Cell | - | - | - | - | [1] 63 63 💬
|
| 491 | Upadacitinib | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [12] 40 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
|
| 492 | Urine sample | - | - | - | - | [5] 49 49, 51, 61, 63, 84 💬
|
| 493 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 494 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 495 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | [5] 61 61, 62, 63, 66, 223 💬
|
| 496 | VAY736 | - | - | - | - | [9] 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
|
| 497 | Veltuzumab | [1] Veltuzumab Veltuzumab | [1] Veltuzumab
Veltuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 46 46, 63 💬
|
| 498 | Vinblastine | [1] Vinblastine Vinblastine | [2] Vinblastine sulfate
Vinblastine sulfate
,
Vinblastine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [3] 34 34, 63, 65 💬
|
| 499 | Vincristine | [1] Vincristine Vincristine | [2] Vincristine sulfate
Vincristine sulfate
,
Vincristine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [5] 26 26, 34, 63, 65, 331 💬
|
| 500 | VIT D | - | - | - | - | [2] 63 63, 227 💬
|
| 501 | Vonoprazan | [1] Vonoprazan Vonoprazan | [1] Vonoprazan
Vonoprazan
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [3] 63 63, 97, 98 💬
|
| 502 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 503 | YTS109 cell injection | - | - | - | - | [2] 49 49, 63 💬
|
| 504 | Zanubrutinib | [1] Zanubrutinib Zanubrutinib | [1] Zanubrutinib
Zanubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [7] 13 13, 48, 61, 63, 222, 300, 331 💬
|
| 505 | Zanubrutinib 160mg/d | [1] Zanubrutinib Zanubrutinib | [1] Zanubrutinib
Zanubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 506 | Zanubrutinib 240mg/d | [1] Zanubrutinib Zanubrutinib | [1] Zanubrutinib
Zanubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 507 | Zanubrutinib 80mg/d | [1] Zanubrutinib Zanubrutinib | [1] Zanubrutinib
Zanubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 508 | ZUBERITAMAB | [1] ZUBERITAMAB ZUBERITAMAB | - | - | - | [2] 63 63, 222 💬
|
| 509 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | [7] 61 61, 62, 63, 66, 109, 222, 223 💬
|